Back to 
UBS Group AG
UBS Group AG
CMND2 quarters
Position history for UBS Group AG's holdings in CLEARMIND MEDICINE INC
No. Ubs exited its CMND (Clearmind Medicine) position in Q2 2026. Its Q1 2026 13F listed 1 shares worth $1. Ubs first reported CMND in Q1 2026 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$1
Total Shares Change
-1
Quarter-by-Quarter History
Other major holders of CMND: XTX Topco Ltd, HRT FINANCIAL LP, JPMORGAN CHASE & CO, ROYAL BANK OF CANADA